. The global low molecular antistatic agents market is estimated to be valued at US$ 502.46 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030
| Founded year: | Not set |
| Funding rounds: | Not set |
| Total funding amount: | Not set |